Literature DB >> 20668928

Crossing over: drug network characteristics and injection risk along the China-Myanmar border.

Chyvette T Williams1, Wei Liu, Judith A Levy.   

Abstract

Border areas are important locations for understanding HIV transmission. This study examines individual and network correlates of border crossing and equipment sharing among methadone maintenance clients in Ruili City, a Chinese city on the Myanmar border. Data are from 298 clients enrolled in the Ruili Methadone Treatment Center. Clients were interviewed about drug use, HIV/AIDS knowledge, treatment motivation, and their social networks. Multinomial and logistic regression analysis were performed. Thirty percent of clients reported injecting in Myanmar. Compared to drug networks that usually inject in China, networks that inject equally in both places (border crossing) are more likely to share equipment. The association between HIV positive status and border-crossing was marginally significant and robust. Results indicate some added degree of risk among clients and drug networks who border-cross to use drugs. More research is needed to understand this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20668928      PMCID: PMC3112302          DOI: 10.1007/s10461-010-9764-2

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  21 in total

1.  HIV vulnerability and mobile populations: Thailand and its borders.

Authors:  A Beesey
Journal:  Dev Bull       Date:  2000-06

2.  Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia.

Authors:  C Beyrer; M H Razak; K Lisam; J Chen; W Lui; X F Yu
Journal:  AIDS       Date:  2000-01-07       Impact factor: 4.177

Review 3.  Drug abuse in China.

Authors:  Chengzheng Zhao; Zhimin Liu; Dong Zhao; Yanhong Liu; Jianhui Liang; Yilang Tang; Zeyuan Liu; Jiwang Zheng
Journal:  Ann N Y Acad Sci       Date:  2004-10       Impact factor: 5.691

4.  Social network dynamics and HIV transmission.

Authors:  R B Rothenberg; J J Potterat; D E Woodhouse; S Q Muth; W W Darrow; A S Klovdahl
Journal:  AIDS       Date:  1998-08-20       Impact factor: 4.177

5.  People and places: behavioral settings and personal network characteristics as correlates of needle sharing.

Authors:  C Latkin; W Mandell; D Vlahov; M Oziemkowska; D Celentano
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-11-01

6.  Race and distance effects on regular syringe exchange program use and injection risks: a geobehavioral analysis.

Authors:  Chyvette T Williams; David S Metzger
Journal:  Am J Public Health       Date:  2010-04-15       Impact factor: 9.308

7.  Cohort study of HIV infection among drug users in Ruili, Longchuan and Luxi of Yunnan Province, China.

Authors:  X W Zheng; J P Zhang; C Q Tian; H H Cheng; X Z Yang; S Duan; D Q Li
Journal:  Biomed Environ Sci       Date:  1993-12       Impact factor: 3.118

8.  Risk factors for HIV infection among drug users in Yunnan province, China: association with intravenous drug use and protective effect of boiling reusable needles and syringes.

Authors:  M Xia; J K Kreiss; K K Holmes
Journal:  AIDS       Date:  1994-12       Impact factor: 4.177

Review 9.  HIV infection and AIDS in China, 1985 through 1994.

Authors:  E S Yu; Q Xie; K Zhang; P Lu; L L Chan
Journal:  Am J Public Health       Date:  1996-08       Impact factor: 9.308

10.  Injecting drug use and HIV infection in southwest China.

Authors:  X Zheng; C Tian; K H Choi; J Zhang; H Cheng; X Yang; D Li; J Lin; S Qu; X Sun
Journal:  AIDS       Date:  1994-08       Impact factor: 4.177

View more
  9 in total

Review 1.  Injection Drug Use Trajectories among Migrant Populations: A Narrative Review.

Authors:  Jason S Melo; Maria Luisa Mittal; Danielle Horyniak; Steffanie A Strathdee; Dan Werb
Journal:  Subst Use Misuse       Date:  2018-01-24       Impact factor: 2.164

2.  Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.

Authors:  Danielle Horyniak; Karla D Wagner; Richard F Armenta; Jazmine Cuevas-Mota; Erik Hendrickson; Richard S Garfein
Journal:  Int J Drug Policy       Date:  2017-07-03

3.  Partner and Relationship Characteristics Determining Intimate Partner Violence Among Women Living with HIV in Ruili, China.

Authors:  Yi Li; Judith A Levy; Ronald C Hershow
Journal:  AIDS Behav       Date:  2022-06-22

Review 4.  Social network approaches to recruitment, HIV prevention, medical care, and medication adherence.

Authors:  Carl A Latkin; Melissa A Davey-Rothwell; Amy R Knowlton; Kamila A Alexander; Chyvette T Williams; Basmattee Boodram
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

Review 5.  HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.

Authors:  Nittaya Phanuphak; Ying-Ru Lo; Yiming Shao; Sunil Suhas Solomon; Robert J O'Connell; Sodsai Tovanabutra; David Chang; Jerome H Kim; Jean Louis Excler
Journal:  AIDS Res Hum Retroviruses       Date:  2015-06-24       Impact factor: 2.205

6.  Spatial analysis on hepatitis C virus infection in mainland China: from 2005 to 2011.

Authors:  Lu Wang; Jiannan Xing; Fangfang Chen; Ruixue Yan; Lin Ge; Qianqian Qin; Liyan Wang; Zhengwei Ding; Wei Guo; Ning Wang
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

7.  An HIV Vaccine for South-East Asia-Opportunities and Challenges.

Authors:  Punnee Pitisuttithum; Supachai Rerks-Ngarm; Robert J O'Connell; Jerome H Kim; Jean-Louis Excler
Journal:  Vaccines (Basel)       Date:  2013-08-14

8.  Exploring stakeholder perceptions of facilitators and barriers to using needle exchange programs in Yunnan Province, China.

Authors:  Morgan M Philbin; Zhang FuJie
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

9.  Spatiotemporal clusters of HIV/AIDS infections caused by drug use and heterosexual contact in Ruili city, China 1989-2016.

Authors:  Li Jiang; Zhoulin Li; Jin Huang; Bang Liu; Yingbo Yang; Lanzhu Lin; Chengbo Wang; Ximei Xie; Xia Peng; Wen Xu; Hong Li
Journal:  BMC Infect Dis       Date:  2019-10-30       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.